Cargando…
Mitochondrial glutamine transporter SLC1A5_var, a potential target to suppress astrocyte reactivity in Parkinson’s Disease
SLC1A5 variant (SLC1A5_var) is identified as a mitochondrial glutamine transporter in cancer cells recently. However, the role of SLC1A5_var in Parkinson’s disease (PD) is completely unknown. Here, we found the significant downregulation of SLC1A5_var in astrocytes and midbrain of mice treated with...
Autores principales: | Liu, Yang, Cao, Lei, Song, Yuting, Kang, Zhengwei, Liu, Ting, Ding, Jianhua, Hu, Gang, Lu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646772/ https://www.ncbi.nlm.nih.gov/pubmed/36351889 http://dx.doi.org/10.1038/s41419-022-05399-z |
Ejemplares similares
-
The neuronal and astrocytic protein SLC38A10 transports glutamine, glutamate, and aspartate, suggesting a role in neurotransmission
por: Hellsten, Sofie V., et al.
Publicado: (2017) -
Dysregulation of Astrocytic Glutamine Transport in Acute Hyperammonemic Brain Edema
por: Zielińska, Magdalena, et al.
Publicado: (2022) -
Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family
por: Freidman, Natasha J., et al.
Publicado: (2022) -
The Glutamine Transporter Slc38a1 Regulates GABAergic Neurotransmission and Synaptic Plasticity
por: Qureshi, Tayyaba, et al.
Publicado: (2019) -
Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis
por: Yuan, Zhuhui, et al.
Publicado: (2022)